India Delays Track-and-Trace Plans

Drug GMP Report
A A
India is giving drug exporters a one-to-two year reprieve on track-and-trace requirements, depending on the size of the operation.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $40.00